UBS O'Connor’s enVVeno Medical NVNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,890
Closed -$962K 398
2025
Q2
$962K Sell
6,890
-1,568
-19% -$185K 0.03% 226
2025
Q1
$779K Hold
8,458
0.02% 204
2024
Q4
$894K Hold
8,458
0.02% 240
2024
Q3
$995K Buy
8,458
+1,864
+28% +$342K 0.02% 276
2024
Q2
$1.21M Buy
6,594
+128
+2% +$22.3K 0.03% 272
2024
Q1
$1.23M Sell
6,466
-286
-4% -$51.3K 0.04% 255
2023
Q4
$1.21M Buy
6,752
+286
+4% +$45.5K 0.04% 247
2023
Q3
$1.22M Buy
6,466
+1,128
+21% +$188K 0.02% 308
2023
Q2
$575K Buy
5,338
+263
+5% +$34.2K 0.01% 435
2023
Q1
$840K Buy
+5,075
New +$949K 0.02% 428
2022
Q4
Sell
-4,278
Closed -$940K 218
2022
Q3
$940K Buy
4,278
+903
+27% +$192K 0.01% 753
2022
Q2
$446K Buy
+3,375
New +$524K ﹤0.01% 823

Other funds holding NVNO